Evidence map›Paper›PMID 29513215›Full record

ArticleeLife2018

The sweet side of vimentin.

Natasha T Snider, Nam-On Ku, M Bishr Omary

Abstract readComment
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Vimentin Dynamics in Viral Infection: Shield or Sabotage?International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Pathophysiological Role of Vimentin Intermediate Filaments in Lung Diseases.Frontiers in cell and developmental biology · 2022
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Natasha T SniderDepartment of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States.ORCID 0000-0001-7663-4585
Nam-On KuInterdisciplinary Program of Integrated OMICS Biomedical science, Graduate School, Yonsei University, Seoul, Republic of Korea.ORCID 0000-0003-3850-0126
M Bishr OmaryDepartment of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, United States.

Funding

CD73 is a multi-functional protein that regulates liver injuryR01DK110355 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SNIDER, NATASHA T · 2017 to 2021
$1.8M
NIDDK NIH HHS R01 DK110355
6 · The paper itself

Abstract

A protein modification called O-linked glycosylation regulates the interactions between vimentin molecules under normal conditions, and the ability of

Indexed as

AcetylglucosamineIntermediate FilamentsGlycosylationProtein Processing, Post-TranslationalVimentinAcetylglucosamineVimentincell biologycell migrationchemical biologyChlamydia trachomatisglycosylationhumanintermediate filamentsO-GlcNAc

Identifiers

PMID29513215
PMCPMC5841928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.